Literature DB >> 18278976

Pharmacological control of acute agitation: focus on intramuscular preparations.

Dan L Zimbroff1.   

Abstract

Acute agitation in the psychiatric emergency setting is a common presentation, which can endanger the patient, caregivers and professional staff. Rapid and effective treatment, followed by ongoing evaluation and maintenance treatment where appropriate, is key to circumvent negative outcomes. Nonpharmacological measures are the first step in treating the acutely agitated patient, and include verbal intervention and physical restraint. Pharmacological treatment is often required to ensure the safety of the patient, caregivers and the treatment team. The need for drug delivery in uncooperative patients favours the use of intramuscular preparations for the acutely agitated patient. Intramuscular treatment options include benzodiazepines, conventional antipsychotics and atypical antipsychotics. Each of these medications offers a unique pharmacological profile that must be considered when treating acutely agitated patients, who may be unwilling or unable to accurately communicate their co-morbid conditions and concomitant medications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278976     DOI: 10.2165/00023210-200822030-00002

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  65 in total

1.  Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.

Authors:  A Dorevitch; N Katz; Z Zemishlany; D Aizenberg; A Weizman
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

Review 2.  Emergency management of agitation in schizophrenia.

Authors:  Catherine A Marco; Jason Vaughan
Journal:  Am J Emerg Med       Date:  2005-10       Impact factor: 2.469

3.  Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

Authors:  J Battaglia; S Moss; J Rush; J Kang; R Mendoza; L Leedom; W Dubin; C McGlynn; L Goodman
Journal:  Am J Emerg Med       Date:  1997-07       Impact factor: 2.469

4.  Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.

Authors:  Horacio Preval; Steven G Klotz; Robert Southard; Andrew Francis
Journal:  Gen Hosp Psychiatry       Date:  2005 Mar-Apr       Impact factor: 3.238

Review 5.  Best clinical practice with ziprasidone IM: update after 2 years of experience.

Authors:  Dan L Zimbroff; Michael H Allen; John Battaglia; Leslie Citrome; Avrim Fishkind; Andrew Francis; Daniel L Herr; Douglas Hughes; Marc Martel; Horacio Preval; Ruth Ross
Journal:  CNS Spectr       Date:  2005-09       Impact factor: 3.790

6.  A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.

Authors:  L San; B Arranz; I Querejeta; S Barrio; J De la Gándara; V Pérez
Journal:  Eur Psychiatry       Date:  2006-05-11       Impact factor: 5.361

7.  Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.

Authors:  Leslie Citrome; Jan Volavka; Pal Czobor; Shlomo Brook; Antony Loebel; Francine S Mandel
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

8.  Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.

Authors: 
Journal:  BMJ       Date:  2003-09-27

9.  A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.

Authors:  Padraig Wright; Karena Meehan; Martin Birkett; Stacy R Lindborg; Cindy C Taylor; Philip Morris; Alan Breier
Journal:  Clin Ther       Date:  2003-05       Impact factor: 3.393

10.  A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients.

Authors:  Flavia Nobay; Barry C Simon; M Andrew Levitt; Graham M Dresden
Journal:  Acad Emerg Med       Date:  2004-07       Impact factor: 3.451

View more
  3 in total

Review 1.  Pharmacologic management of acutely agitated pediatric patients.

Authors:  Loretta Sonnier; Drew Barzman
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

2.  Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular Antipsychotics.

Authors:  Nasratullah Wahidi; Katie M Johnson; Allen Brenzel; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2016-08-15

3.  Issues in the management of acute agitation: how much current guidelines consider safety?

Authors:  Bruno Pacciardi; Mauro Mauri; Claudio Cargioli; Simone Belli; Biagio Cotugno; Luca Di Paolo; Stefano Pini
Journal:  Front Psychiatry       Date:  2013-05-07       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.